Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Teva
UBS
Moodys
US Army
Federal Trade Commission

Generated: August 25, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for GSK2982772

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for GSK2982772

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GSK2982772   Try a Free Trial Heterocyclic amides as kinase inhibitors GlaxoSmithKline Intellectual Property Development Limited (Brentford, Middlesex, GB)   Try a Free Trial
GSK2982772   Try a Free Trial Heterocyclic amides as kinase inhibitors GlaxoSmithKline Intellectual Property Development Limited (Brentford, Middlesex, GB)   Try a Free Trial
GSK2982772   Try a Free Trial Compounds, compositions and methods Denali Therapeutics Inc. (South San Francisco, CA)   Try a Free Trial
GSK2982772   Try a Free Trial Compounds, compositions and methods Denali Therapeutics Inc. (South San Francisco, CA)   Try a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for GSK2982772

Drugname Country Document Number Estimated Expiration Related US Patent
GSK2982772 Argentina 094773 2033-02-15   Try a Free Trial
GSK2982772 Australia 2014217453 2033-02-15   Try a Free Trial
GSK2982772 Brazil 112015019627 2033-02-15   Try a Free Trial
GSK2982772 Canada 2900695 2033-02-15   Try a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Merck
Covington
Deloitte
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.